296 related articles for article (PubMed ID: 20593994)
41. Experimental rodent models of brainstem tumors.
Wu Q; Tyler B; Sukay L; Rhines L; DiMeco F; Clatterbuck RE; Guarnieri M; Carson BS
Vet Pathol; 2002 May; 39(3):293-9. PubMed ID: 12014493
[TBL] [Abstract][Full Text] [Related]
42. Brainstem glioma progression in juvenile and adult rats.
Liu Q; Liu R; Kashyap MV; Agarwal R; Shi X; Wang CC; Yang SH
J Neurosurg; 2008 Nov; 109(5):849-55. PubMed ID: 18976074
[TBL] [Abstract][Full Text] [Related]
43. Split immunity: immune inhibition of rat gliomas by subcutaneous exposure to unmodified live tumor cells.
Volovitz I; Marmor Y; Azulay M; Machlenkin A; Goldberger O; Mor F; Slavin S; Ram Z; Cohen IR; Eisenbach L
J Immunol; 2011 Nov; 187(10):5452-62. PubMed ID: 21998458
[TBL] [Abstract][Full Text] [Related]
44. Cyclooxygenase-2 inhibitor prevents radiation-enhanced infiltration of F98 glioma cells in brain of Fischer rat.
Desmarais G; Charest G; Fortin D; Bujold R; Mathieu D; Paquette B
Int J Radiat Biol; 2015 Aug; 91(8):624-33. PubMed ID: 25912457
[TBL] [Abstract][Full Text] [Related]
45. Establishment of experimental glioma models at the intrinsic brainstem region of the rats.
Sho A; Kondo S; Kamitani H; Otake M; Watanabe T
Neurol Res; 2007 Jan; 29(1):36-42. PubMed ID: 17427273
[TBL] [Abstract][Full Text] [Related]
46. A human brainstem glioma xenograft model enabled for bioluminescence imaging.
Hashizume R; Ozawa T; Dinca EB; Banerjee A; Prados MD; James CD; Gupta N
J Neurooncol; 2010 Jan; 96(2):151-9. PubMed ID: 19585223
[TBL] [Abstract][Full Text] [Related]
47. Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4.
Yang W; Barth RF; Wu G; Ciesielski MJ; Fenstermaker RA; Moffat BA; Ross BD; Wikstrand CJ
Clin Cancer Res; 2005 Jan; 11(1):341-50. PubMed ID: 15671565
[TBL] [Abstract][Full Text] [Related]
48. Infiltration of F98 glioma cells in Fischer rat brain is temporary stimulated by radiation.
Desmarais G; Charest G; Therriault H; Shi M; Fortin D; Bujold R; Mathieu D; Paquette B
Int J Radiat Biol; 2016 Aug; 92(8):444-50. PubMed ID: 27121902
[TBL] [Abstract][Full Text] [Related]
49. Glioblastoma stem cells.
Tabatabai G; Weller M
Cell Tissue Res; 2011 Mar; 343(3):459-65. PubMed ID: 21253762
[TBL] [Abstract][Full Text] [Related]
50. Convection enhanced delivery of carmustine to the murine brainstem: a feasibility study.
Sewing AC; Caretti V; Lagerweij T; Schellen P; Jansen MH; van Vuurden DG; Idema S; Molthoff CF; Vandertop WP; Kaspers GJ; Noske DP; Hulleman E
J Neurosci Methods; 2014 Dec; 238():88-94. PubMed ID: 25263805
[TBL] [Abstract][Full Text] [Related]
51. Novel animal glioma models that separately exhibit two different invasive and angiogenic phenotypes of human glioblastomas.
Inoue S; Ichikawa T; Kurozumi K; Maruo T; Onishi M; Yoshida K; Fujii K; Kambara H; Chiocca EA; Date I
World Neurosurg; 2012 Dec; 78(6):670-82. PubMed ID: 22120277
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of a bispecific biological drug designed to simultaneously target glioblastoma and its neovasculature in the brain.
Oh S; Tsai AK; Ohlfest JR; Panoskaltsis-Mortari A; Vallera DA
J Neurosurg; 2011 Jun; 114(6):1662-71. PubMed ID: 21294620
[TBL] [Abstract][Full Text] [Related]
53. Regression of glioma in rat models by intranasal application of parvovirus h-1.
Kiprianova I; Thomas N; Ayache A; Fischer M; Leuchs B; Klein M; Rommelaere J; Schlehofer JR
Clin Cancer Res; 2011 Aug; 17(16):5333-42. PubMed ID: 21715567
[TBL] [Abstract][Full Text] [Related]
54. D-amino acid oxidase gene therapy sensitizes glioma cells to the antiglycolytic effect of 3-bromopyruvate.
El Sayed SM; Abou El-Magd RM; Shishido Y; Chung SP; Sakai T; Watanabe H; Kagami S; Fukui K
Cancer Gene Ther; 2012 Jan; 19(1):1-18. PubMed ID: 21921941
[TBL] [Abstract][Full Text] [Related]
55. Stereotaxic Implantation of F98 Cells in Fischer Rats: A Syngeneic Model to Investigate Photodynamic Therapy Response in Glioma.
Bulin AL; Adam JF; Elleaume H
Methods Mol Biol; 2022; 2451():203-210. PubMed ID: 35505020
[TBL] [Abstract][Full Text] [Related]
56. Toxicity and delivery methods for the linamarase/linamarin/glucose oxidase system, when used against human glioma tumors implanted in the brain of nude rats.
Girald W; Collin A; Izquierdo M
Cancer Lett; 2011 Dec; 313(1):99-107. PubMed ID: 21955616
[TBL] [Abstract][Full Text] [Related]
57. Liposomal formulations of carboplatin injected by convection-enhanced delivery increases the median survival time of F98 glioma bearing rats.
Shi M; Anantha M; Wehbe M; Bally MB; Fortin D; Roy LO; Charest G; Richer M; Paquette B; Sanche L
J Nanobiotechnology; 2018 Oct; 16(1):77. PubMed ID: 30290821
[TBL] [Abstract][Full Text] [Related]
58. Infiltrating growing pattern xenografts induced by glioblastoma and anaplastic astrocytoma derived tumor stem cells.
Brehar FM; Ciurea AV; Zarnescu O; Bleotu C; Gorgan RM; Dragu D; Matei L
Chirurgia (Bucur); 2010; 105(5):685-94. PubMed ID: 21141095
[TBL] [Abstract][Full Text] [Related]
59. Cryopreservation of neurospheres derived from human glioblastoma multiforme.
Chong YK; Toh TB; Zaiden N; Poonepalli A; Leong SH; Ong CE; Yu Y; Tan PB; See SJ; Ng WH; Ng I; Hande MP; Kon OL; Ang BT; Tang C
Stem Cells; 2009 Jan; 27(1):29-39. PubMed ID: 18845764
[TBL] [Abstract][Full Text] [Related]
60. Effects of the lysosomal destabilizing drug siramesine on glioblastoma in vitro and in vivo.
Jensen SS; Petterson SA; Halle B; Aaberg-Jessen C; Kristensen BW
BMC Cancer; 2017 Mar; 17(1):178. PubMed ID: 28270132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
